- Home
- Biopharmaceutical Industry
- Biopharmaceutical Market and Forecasts, May 2013
Industries
- Biopharmaceutical (141)
- Drug and Medication (107)
- Biotechnology (67)
- Pathology (61)
- Drug Discovery and Development (42)
-
- Pharmaceutical (39)
- Energy & Environment (32)
- Chemical and Material (24)
- Biological Therapy (23)
- Metal and Mineral (17)
- Medical Facility (15)
- Diagnostics (13)
- Blood Supply, Tissue Banking and Transplantation (11)
- Drug Delivery Technology (11)
- Generic Drug (10)
- Renewable Energy (10)
- Education and Training (9)
- Aerospace and Defense (8)
- Genetically Modified Organism, Gmo (8)
- Energy (7)
Top countries
- United States (242)
- World (134)
- India (122)
- China (102)
- Europe (51)
-
- Canada (29)
- Germany (28)
- Australia (28)
- Japan (27)
- South Korea (21)
- United Kingdom (21)
- Russian Federation (17)
- Malaysia (16)
- Singapore (12)
- Netherlands (8)
- Asia (8)
- South Africa (7)
- Italy (7)
- Spain (7)
- Thailand (6)
Publication dates
All regions
-
- Austria (4)
- Belgium (4)
- Czech Republic (4)
- Denmark (5)
- Finland (2)
- France (5)
- Germany (28)
- Greece (2)
- Hungary (1)
- Ireland (6)
- Italy (7)
- Latvia (1)
- Lithuania (5)
- Netherlands (8)
- Norway (2)
- Poland (1)
- Portugal (1)
- Romania (2)
- Russian Federation (17)
- Slovenia (3)
- Spain (7)
- Sweden (4)
- Switzerland (5)
- United Kingdom (21)
-
- Australia (28)
- Austria (4)
- Belgium (4)
- Canada (29)
- Chile (1)
- Czech Republic (4)
- Denmark (5)
- Finland (2)
- France (5)
- Germany (28)
- Greece (2)
- Hungary (1)
- Ireland (6)
- Israel (2)
- Italy (7)
- Japan (27)
- Mexico (2)
- Netherlands (8)
- New Zealand (1)
- Norway (2)
- Poland (1)
- Portugal (1)
- Slovenia (3)
- South Korea (21)
- Spain (7)
- Sweden (4)
- Switzerland (5)
- Turkey (1)
- United Kingdom (21)
- United States (242)
data types
- All
- Company Data (3 438)
- Industry Data
- Country Data (474)
Biopharmaceutical Market and Forecasts, May 2013
You might be interested in: clinical trial, vaccine, cancer, more »
industry reports
Biopharmaceutical Industry in China and India
- Industry report
- March 2012
- 3 pages
... Rather than price. Throughout the next decade we will continue to see a shift toward developing biopharmaceuticals rather than drugs, with these products offering increased profits and protection ...
- Industries: Biopharmaceutical
- Countries: China, India, World
Biopharmaceutical Business Overview
- Industry report
- August 2011
- 37 pages
... Response rate 53% Complete response rate syntarga data: Trastuzumab adc: cures in mouse model Trastuzumab ineffective why moving into biopharmaceuticals Increasing competition on small molecules ...
- Industries: Biopharmaceutical
World Biopharmaceutical Industry Brief
- Industry report
- June 2012
- 7 pages
... Approximately $172.0 Million in 2010 to $3,987.0 Million in 2017 at a cagr of 56.7%. There is a huge opportunity for biopharmaceutical testing services as new biologics and biosimilars are expected to emerge ...
- Industries: Biopharmaceutical
- Countries: United Kingdom, World, Europe
Biopharmaceutical Business Brief
- Industry report
- August 2011
- 14 pages
... Backbone as well as modification of amino acids f silicone oil/gels may have adjuvant properties in animals but are not immunogenic per se. No case studies with biopharmaceutical products have been published ...
- Industries: Biopharmaceutical
Biopharmaceutical Market (biopharmaceutical, growth hormone, biogeneric) in Australia, China and India
- Industry report
- March 2012
- 2 pages
- by Corporation
... Gen S interest in hefei-scigen-bioton biopharmaceutical company ltd the board of directors of scigen limited (asx: sie) (the Scigen ) Announced today that it has closed the transaction on the sale of sci ...
- Industries: Biopharmaceutical
- Countries: Australia, China, India
Biopharmaceutical Sector (biopharmaceutical, growth hormone, biogeneric) in Australia, China and India
- Industry report
- March 2012
- 2 pages
... Gen S interest in hefei-scigen-bioton biopharmaceutical company ltd the board of directors of scigen limited (asx: sie) (the Scigen ) Announced today that it has closed the transaction on the sale of sci ...
- Industries: Biopharmaceutical
- Countries: Australia, China, India
Biosimilar Market (biosimilar, biopharmaceutical) in Europe
- Industry report
- July 2011
- 7 pages
... As is required in the eu and other non-eu highly regulated markets. All biopharmaceuticals are inherently variable due to the fact that they are produced from living organisms. This variability exists within ...
- Industries: Biopharmaceutical
- Countries: Europe
Biopharmaceutical in Iran : Innovation and Technology Trends
- Industry report
- August 2012
- 6 pages
... Production of different proteins used as biopharmaceutics, vaccine cands or diagnostic kit components. In collaboration with international center for biotechnology and genetic engineering of cuba ...
- Industries: Biopharmaceutical
- Countries: Iran
Biopharmaceutical Business (biopharmaceutical, growth hormone, biogeneric) in Australia, India and Singapore
- Industry report
- June 2012
- 2 pages
... Gen scigen ltd is a progressive biopharmaceutical company involved in co-developing and marketing genetically engineered biopharmaceutical products for human healthcare. Scigen focuses in the areas ...
- Industries: Biopharmaceutical
- Countries: Australia, India, Singapore
Biopharmaceutical Industry (biopharmaceutical, growth hormone) in Australia, Singapore and India
- Industry report
- June 2012
- 2 pages
... Authority to allot & issue shares 527,849,235 284,986 - - carried about scigen scigen ltd is a progressive biopharmaceutical company involved ...
- Industries: Biopharmaceutical
- Countries: Australia, Singapore, India
Reportlinker.com © Copyright 2013. All rights reserved.
